Turmeric Acquisition Corp.
TMPMW
NASDAQ Capital Market0.00
USD
- -
- -
CIK
0001823524
Return %
Stock
S&P500
1Y
- -
26.84
3Y
-99.91
77.03
5Y
-99.99
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- IPO Date
- Dec 24, 2020
- CIK
- 0001823524
- Similar Companies
- Business
- Turmeric Acquisition Corp is a special purpose acquisition company (SPAC) incorporated in 2020 and headquartered in Cambridge, Massachusetts. The company operates as a subsidiary of Turmeric Management, LLC and primarily focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities, with a strategic intent to identify and acquire a business in the healthcare or healthcare-related industry. Turmeric Acquisition Corp currently does not have significant operations of its own or manufacturing and sales activities but acts as an investment vehicle targeting acquisitions in healthcare. Its corporate activities include engaging with potential targets and structuring business combinations but it has not consummated a business combination as it redeemed all public shares in October 2022 and ceased significant operations. There are no available records of Turmeric Acquisition Corp manufacturing or directly offering products or services under its own brand. Instead, its business model is centered on facilitating the public offering and acquisition process for a target company with healthcare focus. As of now, the company has not announced any recent major partnerships, acquisitions, or product launches post its public share redemption in 2022, which effectively ended its active public market presence. Its latest significant corporate event was the redemption of all its publicly issued Class A shares in October 2022, following the failure to complete a qualifying business combination within the required time frame. The company’s intent remains focused on healthcare-related acquisitions, leveraging the management expertise of Turmeric Management, LLC, but no active operating subsidiaries or specific product lines are currently reported. Geographic operations are primarily tied to corporate activities in the United States, with headquarters in Massachusetts. Turmeric Acquisition Corp serves institutional investors and capital markets interested in the healthcare sector through the SPAC mechanism rather than through direct product or service offerings. Hence, Turmeric Acquisition Corp is positioned as an acquisition and investment vehicle rather than a direct producer or seller of goods or services, with its main activities focused on identifying and completing a merger or acquisition within the healthcare industry, with no recent major operational developments or new product introductions reported since late 2022.